ENFN - Enfusion GAAP EPS of $0.01 beats by $0.02 revenue of $40.52M beats by $0.52M
2023-03-07 07:55:02 ET
- Enfusion press release ( NYSE: ENFN ): Q4 GAAP EPS of $0.01 beats by $0.02 .
- Revenue of $40.52M (+27.2% Y/Y) beats by $0.52M .
- 2023 Outlook: Revenue of $185M-$190M vs consensus of $188.13M, Adj. EBITDA of $32M-$34M
For further details see:
Enfusion GAAP EPS of $0.01 beats by $0.02, revenue of $40.52M beats by $0.52M